FREDI, MICAELA
 Distribuzione geografica
Continente #
NA - Nord America 7.561
AS - Asia 3.575
EU - Europa 2.485
SA - Sud America 691
Continente sconosciuto - Info sul continente non disponibili 232
AF - Africa 100
OC - Oceania 10
Totale 14.654
Nazione #
US - Stati Uniti d'America 7.375
SG - Singapore 1.281
CN - Cina 965
BR - Brasile 576
IT - Italia 544
DE - Germania 425
HK - Hong Kong 416
UA - Ucraina 374
VN - Vietnam 265
BD - Bangladesh 218
FI - Finlandia 196
FR - Francia 192
GB - Regno Unito 186
RU - Federazione Russa 149
TR - Turchia 129
IE - Irlanda 108
CA - Canada 94
IN - India 86
PL - Polonia 80
MX - Messico 51
SE - Svezia 46
AR - Argentina 43
ZA - Sudafrica 36
IQ - Iraq 33
PK - Pakistan 28
NL - Olanda 27
ES - Italia 24
AT - Austria 22
ID - Indonesia 21
EC - Ecuador 19
JP - Giappone 18
MA - Marocco 17
BE - Belgio 14
CZ - Repubblica Ceca 14
LT - Lituania 14
SA - Arabia Saudita 14
CO - Colombia 12
KE - Kenya 11
PH - Filippine 11
PY - Paraguay 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 9
AL - Albania 9
AU - Australia 9
IL - Israele 9
PT - Portogallo 9
UZ - Uzbekistan 9
HN - Honduras 8
KZ - Kazakistan 8
NG - Nigeria 8
CR - Costa Rica 7
MK - Macedonia 7
NP - Nepal 7
AZ - Azerbaigian 6
DZ - Algeria 6
ET - Etiopia 6
TT - Trinidad e Tobago 6
CL - Cile 5
EG - Egitto 5
GR - Grecia 5
JM - Giamaica 5
JO - Giordania 5
MY - Malesia 5
NO - Norvegia 5
RS - Serbia 5
CH - Svizzera 4
KR - Corea 4
LV - Lettonia 4
PE - Perù 4
TH - Thailandia 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
LB - Libano 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AO - Angola 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
LU - Lussemburgo 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BM - Bermuda 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
Totale 14.406
Città #
Fairfield 717
Singapore 708
Ashburn 659
Woodbridge 482
Hong Kong 413
San Jose 381
Houston 308
Jacksonville 288
The Dalles 275
Cambridge 266
Beijing 248
Seattle 239
Wilmington 232
Chandler 219
Ann Arbor 213
Los Angeles 210
Chicago 204
New York 203
Princeton 174
Council Bluffs 166
Helsinki 143
Dallas 108
Dublin 108
Lauterbourg 108
Istanbul 104
Columbus 82
Ho Chi Minh City 82
Salt Lake City 82
Munich 76
Warsaw 76
Brescia 69
Nanjing 69
Hanoi 60
Buffalo 59
Santa Clara 49
Moscow 48
San Francisco 48
Shanghai 48
São Paulo 47
Redondo Beach 45
London 40
Milan 40
Phoenix 36
San Diego 36
Des Moines 34
Elk Grove Village 32
Nanchang 32
Nuremberg 32
Orem 32
Tampa 30
Turku 28
Lancaster 27
Montreal 26
Changsha 25
Shenyang 25
Johannesburg 24
Brooklyn 23
Rome 23
Atlanta 22
Chennai 22
Hebei 22
Mexico City 22
Tianjin 21
Denver 19
Romola 18
Tokyo 18
Miami 17
Jiaxing 16
Toronto 16
Bergamo 15
Frankfurt am Main 15
Brussels 14
Manchester 14
Ottawa 14
Cagliari 13
Porto Alegre 13
Belo Horizonte 12
Dong Ket 12
Jinan 12
Rio de Janeiro 12
Stockholm 12
Washington 12
Amsterdam 11
Brasília 11
Da Nang 11
Haiphong 11
Hangzhou 11
Sterling 11
Vienna 11
Biên Hòa 10
Dearborn 10
Dhaka 10
Dulles 10
Naples 10
Nürnberg 10
Rozzano 10
Verona 10
Baghdad 9
Campinas 9
Falkenstein 9
Totale 9.228
Nome #
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 709
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 240
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 239
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 222
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 208
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 194
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 193
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 190
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 189
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 186
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 182
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 181
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 179
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 179
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 178
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 177
Antiphospholipid antibodies mediate autoimmunity against dying cells. 173
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 171
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 171
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 170
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 166
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 164
The clinico-serological spectrum of overlap myositis 161
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 159
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 158
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 156
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 155
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 153
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 148
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 147
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 144
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 143
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases 142
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 142
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 142
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 142
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 141
IRF5 is associated with primary antiphospholipid syndrome,but is not a major risk factor 137
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 134
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 133
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 132
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 130
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 130
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 130
Myositis autoantibodies and clinical phenotypes 128
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 128
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 128
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 127
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 126
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 122
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 122
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications 121
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 118
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 117
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 117
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 117
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 115
ANTIPHOSPHOLIPID ANTIBODIES AND CEREBROVASCULAR EVENTS. WHICH FACTORS ASSOCIATE WITH ONSET AND RECURRENCE? - POSTER TOURS 114
Autoimmune polyglandular syndrome type 4: experience from a single reference center 110
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis 108
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 108
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 107
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 106
Should we treat congenital heart block with fluorinated corticosteroids? 103
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 102
Managing puerperium in patients with systemic autoimmune diseases: an update 101
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry 99
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 98
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 98
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 96
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort 95
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 95
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 94
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 94
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 94
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. 93
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 91
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 91
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 88
Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study 88
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 86
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses 85
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 84
Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis 82
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 81
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 81
Neutrophil Extracellular Traps in the Autoimmunity Context. 81
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 81
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 79
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 78
Association of Natural Killer Cell Ligand Polymorphism, HLAC Asn80Lys, with the Development of Anti-SSA/Ro Associated Congenital Heart Block 76
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 75
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 74
Systemic lupus erythematosus: state of the art on clinical practice guidelines 72
Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women 71
Editorial: Into the heart of systemic autoimmune diseases. 68
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 global rheumatology alliance 66
Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation 66
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 65
Clinical phenotype of Graves' disease in Autoimmune Polyglandular Syndrome or as isolated disease: the GRAPHE study 65
Totale 13.195
Categoria #
all - tutte 76.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022626 0 0 54 41 12 54 26 60 44 95 71 169
2022/2023752 102 7 9 43 74 208 11 90 126 7 35 40
2023/2024927 55 21 79 114 58 151 37 49 198 26 20 119
2024/20252.702 23 38 40 238 195 186 144 92 222 209 579 736
2025/20264.868 402 618 325 672 470 322 685 174 253 454 256 237
2026/2027572 222 269 81 0 0 0 0 0 0 0 0 0
Totale 14.654